For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Synchroneuron, Inc.

USPTO Granted Patents = 15

% Expired Patents = 13.3

EPO Patents = 2

Forward Citations = 372

Loading Chart...

Loading Chart...

6 inventors (with patents filed for the assignee):

Barry S Fogel (15 out of 20 patents)

William D Kerns (5 out of 5 patents)

Kei-Lai Fong (5 out of 5 patents)

4. San-Laung Chow (1 out of 7 patents)

5. Edward Lin (1 out of 1 patent)

6. David N Wong (1 out of 34 patents)

7. Edward Lin (0 patent)

15 patents: Sort by Forward Citations

1. 10512621 - Methods of treating posttraumatic stress disorder with acamprosate salts (2019-12-24),

2. 10166207 - Acamprosate formulations, methods of using the same, and combinations comprising the same (2019-01-01),

3. 9427420 - Acamprosate formulations, methods of using the same, and combinations comprising the same (2016-08-30),

4. 9421179 - Acamprosate formulations, methods of using the same, and combinations comprising the same (2016-08-23),

5. 9421178 - Acamprosate formulations, methods of using the same, and combinations comprising the same (2016-08-23),

6. 7745493 - Methods of treating tardive dyskinesia and other movement disorders (2010-06-29),

7. 7498361 - Methods of treating tardive dyskinesia and other movement disorders (2009-03-03),

8. 6689816 - Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders (2004-02-10),

9. 6391922 - Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders (2002-05-21),

10. 6294583 - Methods of treating tardive dyskinesia and other movement disorders (2001-09-25),

11. 6159944 - Method for treating painful conditions of the anal region and (2000-12-12),

12. 6117877 - Method for treating painful conditions of the anal region and (2000-09-12),

13. 6057373 - Methods of treating tardive dyskinesia and other movement disorders (2000-05-02),

14. 5952389 - Methods of treating tardive dyskinesia and other movement disorders (1999-09-14),

15. 5866585 - Methods of treating tardive dyskinesia using NMDA receptor antagonists (1999-02-02),

Synchroneuron, Inc. is a leading biotechnology company dedicated to developing novel therapies for neurological disorders. Our focus is on leveraging a deep understanding of synaptic transmission to pioneer groundbreaking treatments that address the underlying causes of conditions such as epilepsy, Parkinson's disease, and neuropathic pain. Through innovative research and strategic partnerships, we are committed to improving the lives of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

15 Patents

#169 in Cambridge, MA

#1,271 in Massachusetts

#21,017 in US

#39,822 in the World

Cambridge, MA, United States of America

Synchroneuron, Inc.

Forward Citations = 372

6 inventors:

Barry S Fogel (15 out of 20 patents)

William D Kerns (5 out of 5 patents)

Kei-Lai Fong (5 out of 5 patents)

4. San-Laung Chow (1 out of 7 patents)

5. Edward Lin (1 out of 1 patent)

Please report any incorrect information to [email protected]

Loading…